Bottom line
GCASX vs IJR: the short answer
GCASX (The Gabelli Small Cap Growth Fund) and IJR (iShares Core S&P Small-Cap ETF) are both mutual funds.
IJR is cheaper at 0.06% vs 1.38% — a difference of $132 a year per $10,000 invested.
Over five years, GCASX returned +8.5% a year vs +7.2% for IJR.
GCASX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
GCASX vs IJR side by side
| GCASX | IJR | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Innovator | iShares |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 1.38% | 0.06% |
| Annual cost per $10k | $138 | $6 |
| 10-yr cost on $10k (prospectus) | $2,136 | $77 |
| Max front load | 5.75% | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +2.5% | +5.9% |
| 5-yr return (annualized) | +8.5% | +7.2% |
| 10-yr return (annualized) | +9.4% | +9.8% |
| Best quarter | +23.4% | +31.3% |
| Worst quarter | −29.3% | −32.7% |
| Net assets (fund) | $1.9B | $111.3B |
| Number of holdings | 394 | 683 |
| Portfolio turnover | 1% | 25% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
2 of GCASX's top 25 holdings also appear in IJR's top 25.
| Holding | GCASX | IJR |
|---|---|---|
| Ryman Hospitality Properties Inc | 1.34% | 0.44% |
| Federal Signal Corp | 1.04% | 0.42% |
Source: SEC Form N-PORT
GCASX top 10
- Ametek Inc — 3.90%
- Gorman Rupp Company (the) — 3.34%
- Mueller Industries Inc — 3.20%
- Crane Company — 2.97%
- Gatx Corp — 2.44%
- Kkr & Co. Inc — 2.15%
- Rush Enterprises Inc — 1.79%
- United Rentals Inc — 1.77%
- Moog Inc — 1.76%
- Myers Industries Inc — 1.67%
IJR top 10
- Blackrock Global — 5.45%
- Blackrock Cash Funds — 2.08%
- Formfactor Inc — 0.67%
- Viasat Inc — 0.66%
- Molina Healthcare Inc — 0.64%
- Argan Inc — 0.60%
- Brightspring Health Services Inc — 0.60%
- Element Solutions Inc — 0.59%
- Maxlinear Inc — 0.58%
- Krystal Biotech Inc — 0.53%
FAQ
What is the difference between GCASX and IJR?
Which is cheaper, GCASX or IJR?
Should I own both GCASX and IJR?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.